Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 10, 2021New England Journal of MedicineOpen Access

Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

EDEric J. DuncavageWashington University in St. LouisMSMolly C. SchroederWashington University in St. LouisMOMichele O’LaughlinJames S. McDonnell Foundation

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Duncavage et al. (2021) studied this question.

synapsesocial.com/papers/69dffb672833447a7e255d2ahttps://doi.org/10.1056/nejmoa2024534
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia2013 · 5,266 citations
  2. 2Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome2018 · 219 citations
  3. 3<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes2016 · 780 citations
  4. 4Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel2016 · 5,994 citations
  5. 5Mutation Clearance after Transplantation for Myelodysplastic Syndrome2018 · 119 citations